LBA56 ORIENT-12: Sintilimab plus gemcitabine and platinum (GP) as first-line (1L) treatment for locally advanced or metastatic squamous non-small-cell lung cancer (sqNSCLC)

作者：Caicun Zhou, Lin Wu, Yun Fan, Zhaoguang Wang, Luwei Liu, G. Chen, L. Zhang, Dingzhi Huang, Shundong Cang, Zhixiong Yang, Jianying Zhou, Chengzhi Zhou, Baopu Li, J. Li, Min Fan, W. Zhang, Wei Yang, Shuxiao Wang, Hui Zhou · 发表于：Annals of Oncology · 年份：2020 · DOI：10.1016/j.annonc.2020.08.2289 · 被引用次数：17 · 研究领域：Cancer Immunotherapy and Biomarkers、Lung Cancer Treatments and Mutations、Cancer Genomics and Diagnostics